Montana 2025 2025 Regular Session

Montana House Bill HB371 Amended / Bill

                     - 2025 
69th Legislature 2025 	HB0371.2
- 1 - Authorized Print Version – HB 371 
1 HOUSE BILL NO. 371
2 INTRODUCED BY G. KMETZ, L. SCHUBERT, K. LOVE, T. SHARP, R. GREGG, E. TILLEMAN, T. 
3 MANZELLA, D. EMRICH, S. GIST, R. MARSHALL, J. SCHILLINGER, L. DEMING, S. MANESS
4
5 A BILL FOR AN ACT ENTITLED: β€œAN ACT PROHIBITING THE ADMINISTRATION OF GENE-BASED 
6 VACCINES FOR INFECTIOUS DISEASES INTO HUMANS IN THE STATE OF MONTANA; PROVIDING A 
7 DEFINITION; AND PROVIDING A PENALTY.”
8
9 WHEREAS, the mRNA vaccines have caused enormous numbers of deaths, disabilities, and serious 
10 adverse events; and
11 WHEREAS, no long-term studies have been completed regarding fertility, teratogenicity, mutagenicity, 
12 or oncogenicity; and
13 WHEREAS, recipients are not given informed consent; and
14 WHEREAS, the mRNA vaccines may integrate into the human genome and be passed onto the next 
15 generation; and
16 WHEREAS, the mRNA vaccines are contaminated with DNA, metallic particles, and other unknown 
17 nanoparticles; and
18 WHEREAS, the mRNA vaccines may shed to others and cause side effects or harm.
19
20 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:
21
22 NEW SECTION. Section 1. FOR INFECTIOUS DISEASES. (1) 
23 A person may not provide or administer a gene-based vaccine FOR INFECTIOUS DISEASES to a human within the 
24 state.
25 (2) A person who violates this section is guilty of a misdemeanor and is subject to a $500 fine for 
26 each incident.
27 (3) The appropriate licensure board within the Montana department of labor and industry shall 
28 review the license of a person who is licensed under Title 37 and who violates this section.  - 2025 
69th Legislature 2025 	HB0371.2
- 2 - Authorized Print Version – HB 371 
1 (4) (A) For the purposes of this section, "gene-based vaccine FOR INFECTIOUS DISEASES" means a 
2 vaccine  developed using messenger ribonucleic acid (mRNA) technology, modified 
3 messenger ribonucleic acid technology, self-amplifying messenger ribonucleic acid technology, or 
4 deoxyribonucleic acid technology.
5 (B) T
6.
7
8 NEW SECTION. Section 2.  [Section 1] is intended to be codified as an 
9 integral part of Title 45, chapter 5, and the provisions of Title 45, chapter 5, apply to [section 1].
10 - END -